| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 209 | 2022 |
| Class distance weighted cross-entropy loss for ulcerative colitis severity estimation G Polat, I Ergenc, HT Kani, YO Alahdab, O Atug, A Temizel Annual Conference on Medical Image Understanding and Analysis, 157-171, 2022 | 23 | 2022 |
| Improving the computer-aided estimation of ulcerative colitis severity according to mayo endoscopic score by using regression-based deep learning G Polat, HT Kani, I Ergenc, Y Ozen Alahdab, A Temizel, O Atug Inflammatory Bowel Diseases 29 (9), 1431-1439, 2023 | 21 | 2023 |
| Femoral vein wall thickness measurement may be a distinctive diagnostic tool to differentiate Behçet’s disease with intestinal involvement and Crohn’s Disease F Alibaz-Oner, R Ergelen, I Ergenc, G Seven, A Yazıcı, A Cefle, C Bes, ... Digestive Diseases and Sciences 66, 2750-2755, 2021 | 17 | 2021 |
| Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint F Karow, B Smiljanovic, JR Grün, D Poddubnyy, F Proft, A Talpin, C Hue, ... Arthritis Research & Therapy 23, 1-15, 2021 | 15 | 2021 |
| Diagnostic performance of lactate dehydrogenase (LDH) isoenzymes levels for the severity of COVID-19 I Ergenc, E Capar, SB Erturk, G Bahramzade, F Atalah, D Kocakaya, ... Journal of medical biochemistry 42 (1), 16, 2023 | 13 | 2023 |
| Evaluation of the impact of metabolic syndrome on fibrosis in metabolic dysfunction-associated fatty liver disease HT Kani, CO Demirtas, C Keklikkiran, I Ergenc, S Mehdiyev, E Akdeniz, ... The Turkish Journal of Gastroenterology 32 (8), 661, 2021 | 11 | 2021 |
| The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients I Ergenc, B Gozaydinoglu, C Keklikkiran, Y Yilmaz Hepatology forum 4 (2), 69, 2023 | 9 | 2023 |
| Labeled images for Ulcerative Colitis (LIMUC) dataset G Polat, HT Kani, I Ergenc, YO Alahdab, A Temizel, O Atug Accessed March, 2022 | 8 | 2022 |
| Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study CO Demirtas, C Keklikkiran, I Ergenc, B Erturk Sengel, G Eskidemir, ... International Journal of Clinical Practice 75 (9), e14363, 2021 | 8 | 2021 |
| High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis I Ergenc, P Gokcen, G Adali, HT Kani, CO Demirtas, F Gunduz, CA Celikel, ... Hepatology Forum 2 (1), 20, 2021 | 7 | 2021 |
| Radiological quantification of sarcopenic obesity and its role in chronic liver disease severity C Cimsit, M Kursun, O Demircioglu, F Dilber, CO Demirtas, I Ergenc Academic Radiology 30, S124-S131, 2023 | 6 | 2023 |
| Staphylococcus aureus costochondritis and chest wall abscess in a COVID-19 patient treated with tocilizumab İ Ergenç, CŞ Toprak, Z Odabaşı Turkish journal of physical medicine and rehabilitation 67 (3), 382, 2021 | 6 | 2021 |
| P099 Evaluation of endoscopic mayo score with an artificial intelligence algorithm HT Kani, I Ergenc, G Polat, Y Ozen Alahdab, A Temizel, O Atug Journal of Crohn's and Colitis 15 (Supplement_1), S195-S196, 2021 | 6 | 2021 |
| High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease I Ergenc, C Ismail Basa, A Uzum, S Sahin, HT Kani, R Aslan, A Tufan, ... Nutrition in Clinical Practice 39 (3), 557-567, 2024 | 5 | 2024 |
| Causes of erectile dysfunction in non-alcoholic fatty liver disease HT Kani, TE Sener, UE Aykut, CO Demirtas, C Keklikkiran, I Ergenc, ... Hepatology Forum 2 (2), 60, 2021 | 5 | 2021 |
| Validation and reliability of the Turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn’s disease HT Kani, İ Ergenç, H Arıkan, Z Komesli, B Seyrek, CÖ Demirtaş, ... The Turkish Journal of Gastroenterology 31 (8), 566, 2020 | 5 | 2020 |
| Biologic therapy carries a very low risk of reactivation in hepatitis B surface antigen-negative phase of hepatitis B İ Ergenç, HT Kani, M Karabacak, EC Özer, S Mehdiyev, F Jafarov, ... The Turkish Journal of Gastroenterology 34 (2), 156, 2023 | 4 | 2023 |
| Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: a forensic autopsy study I Ergenc, E Kara, ME Yilmaz, CO Demirtas, C Keklikkiran, T Das, Y Buyuk, ... Heliyon 10 (15), 2024 | 2 | 2024 |
| Drug eruption: A mimicker of Coronavirus disease-2019 rash T Ergun, İ Ergenç, S Seven, D Seçkin, EC Özer, M Aktaş, ET Tigen Turkderm Turk Arch Dermatol Venereol 56 (1), 34-38, 2022 | 2 | 2022 |
